FDA Approves IDE for Avisi Technologies’ VisiPlate...
Category : Approval/Launch 15 October 2025Avisi Technologies, Inc., a clinical-stage ophthalmic medical device company developing sight-saving...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Quotient Sciences and Biorasi Partner to Deliver F...
Category : Licensing/Collaboration Deal 15 October 2025Collaboration streamlines transition from first-in-human studies to proof-of-concept Quotient Sci...
Ascletis Pharma Selects ASC35 as Once-Monthly GLP-...
Category : Clinical Trial Update 13 October 2025Ascletis Pharma Inc. (HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agoni...
Cidara Therapeutics’ CD388 Receives FDA Breakthrou...
Category : ODD/BTA/FTA Status 13 October 2025Cidara Therapeutics announced that the U.S. FDA has granted Breakthrough Therapy designation for CD3...
Dr Reddy’s and Zydus Lifesciences Initiate US Reca...
Category : Warning/Recalls 13 October 2025Dr Reddy’s Laboratories and Zydus Lifesciences are recalling products in the United States due...
Latest Newsletter Post
-
Quotient Sciences and Biorasi Partn..
15 October 2025
-
FDA Approves IDE for Avisi Technolo..
15 October 2025
-
Dr Reddy’s and Zydus Lifesciences I..
13 October 2025
-
Cidara Therapeutics’ CD388 Receives..
13 October 2025
-
Ascletis Pharma Selects ASC35 as On..
13 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com